Desktop Genetics

DeskGen has developed a software platform that unlocks the promise of genome editing.

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location London, GB-ENG, United Kingdom
  • Currency GBP
  • Founded August 2012
  • Employees 7
  • Website deskgen.com

Company Summary

Genome editing, a technique allowing scientists to make precise genetic modifications in plant, animal and human cells, is transforming Life Sciences research. DeskGen has developed a software platform that unlocks the promise of genome editing. To date, the platform has enabled thousands of customers to design and purchase bespoke consumables for their research on demand.

Team

  • Riley Doyle
    CEO & CTO

    Genentech alum with over a decade of genetic engineering experience

  • Edward Perello
    CBO

    Synthetic biologist a broad network in the academic and government sectors

  • Victor Dillard
    COO & CFO

    Flagship Ventures alum with a track record in fundraising and closing strategic sales

Advisors

  • Field Fisher Waterhouse, Mintz Levin, Caliber IP
    Lawyer
    Unconfirmed

Previous Investors

  • Carpe Diem Trust - Cambridge University Entrepreneurs
    Unconfirmed
    Healthbox Sanbox Industries
    Unconfirmed
    UK Technology Strategy Board
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free